Living With GIST: 10 Years of Molecularly Targeted Therapy

On April 9, 2010 GIST patients and familiy members flocked to Dana-Farber for a day-long event organized by George Demetri, MD and Suzanne George, MD to celebrate the 10-year anniversary of the first drug for treatment of GIST, imatinib (Gleevec).

You can see the agenda HERE

Below are some photos from this memorable event!

A panel of GIST patients from the original B2222 trial told their stories as 10-year-plus survivors.

Les Anderhub tells his story… 

 

Dr. Demetri introduces the expert panelists:  Burton Eisenberg, MD; Annick van den Abbeele, MD, Meg von Mehren, MD; Charles Blanke, MD; and Christopher Corless, MD.

Dr. Ed Benz, head of Dana-Farber Cancer Institute, addresses the crowd. 

 Dr. Demetri and Dorothy McBride.

Dr. Eisenberg converses with Brian McBride.

A group of patients met for dinner the night before the event.

Marina met up with Barbara.

Comments are closed.

PHP Code Snippets Powered By : XYZScripts.com